Harry Boxer
The Technical Trader
The stock market indices had an unusual day. First they were up in the morning, by midday they reached their peak, and came down hard. By midafternoon they reached their bottom, and then rallied in the last hour, only to pull back at the close to finish down on the day.
Net on the day, the Dow was down 31.57 at 17,685.09. The S&P 500 was down 4.21 to 2059.74. The Nasdaq 100 was down 7.22 to 4483.66.
Advance-declines were positive by 314 issues on the New York Stock Exchange, and 2 to 1 positive on the Nasdaq. Up/down volume was 18 to 17 positive on New York, total volume of 3 1/2 billion shares traded. The Nasdaq traded 45 issues lower and had a 9 to 8 positive volume ratio.
TheTechTrader.com board was mixed as well, but the big boys on Nasdaq did not have a nice time. Priceline.com (PCLN) was down 28.07 to 1288.96, Google Inc. (GOOG) down 5.58 to 744.95, Apple Inc. (AAPL) down just 57 cents to 108.99, Amazon.com Inc. (AMZN) 5.05 to 593.64, and Netflix Inc. (NFLX) was up, but by just 4 cents to 102.23.
Baidu, Inc. (BIDU) was up 1.00 to 191.88, First Solar, Inc. (FSLR) down 50 cents to 68.47, and Facebook, Inc. (FB) down 60 cents to 114.10.
Tesla Motors, Inc. (TSLA) had a pretty good day, up 2.88 to 229.77.
The biotech’s had a very good day, surprisingly. Juno Therapeutics Inc. (JUNO) was up 1.16 to 38.09, ACADIA Pharmaceuticals Inc. (ACAD) up 1.95 to 27.96, and NewLink Genetics Corporation (NLNK) 1.04 to 18.20.
The Direxion Daily S&P Biotech Bull 3X ETF (LABU) ran 2.29 to 27.42.
Checking the TheTechTrader.com percent-gain leaderboard, the big winner today was Genocea Biosciences, Inc. (GNCA), up 3.77 to 7.74, or 95%, on 22 million shares, and traded to 8.45 in afterhours. That was 5500% more volume than average. Sky Solar Holdings, Ltd. (SKYS) thrust 1.03 to 2.26, or 84%, on 2.6 million shares. ProQR Therapeutics N.V. (PRQR) gained 1.24 to 4.88, or 35%, on 2 million shares.
Medivation, Inc. (MDVN) had a beautiful session, running up to 46.87, before pulling back to close up 8.59 to 45.98, or 23%, on 16 million shares. Santander Consumer USA Holdings Inc. (SC) jumped 1.61 to 10.50, or 18%, on 8.6 million shares. Dynagas LNG Partners LP (DLNG) climbed 1.78 to 11.40, or 18.5%. SciClone Pharmaceuticals, Inc. (SCLN) advanced 1.33 to 11.00, or 14%, on 2.4 million shares. Fitbit Inc. (FIT) coasted its way up, up 1.75 to 15.15, or 13%, on 21 million shares.
Among other gainers, Inogen, Inc. (INGN) was up 2.97 to 44.98, bluebird bio, Inc. (BLUE) up 2.50 to 42.50, Neurocrine Biosciences Inc. (NBIX) up 2.40 to 39.55, and Incyte Corporation (INCY) 4.12 to 72.47.
Primo Water Corporation (PRMW) had an interesting day, up 63 cents to 10.09.
Stepping back and reviewing the hourly chart patterns, the indices started the day with a rally, they pulled back midmorning, got to the session highs midday, and then rolled over pretty hard, even taking out important support slightly before the rally late in the day, and in the last 5-10 minutes they really saw a little bit of a hard pullback into the close to finish negative on the day.
Let’s see what happens tomorrow.
Good Trading!
In using any portion of The Technical Trader, you agree to the Terms and Conditions governing the use of the service as described in this disclaimer. Our disclaimers, policies and terms are subject to change without notice. The Technical Trader (www.thetechtrader.com) is published by Century-Pacific Investments and AdviceTrade, Inc., both of which are publishers. The Web site is maintained by Codexia, LLC. None of these firms, nor Mr. Boxer, is registered as a broker-dealer or investment adviser either with the U.S. Securities and Exchange Commission or with any state securities authority. Each trade mentioned in the diary and other sections of The Technical Trader is hypothetical and is not an actual trade. Mr. Boxer and employees of Century-Pacific, AdviceTrade and Codexia are not allowed to have personal positions in stocks mentioned in the diary and other sections of The Technical Trader. This policy, first announced to subscribers on June 2, 2004, gave Mr. Boxer a deadline that was extended to July 30, 2004 for liquidating any existing personal holdings in stocks mentioned on the site. Our holdings page, in which Mr. Boxer listed his personal positions in stocks mentioned on the site, was removed at that time. The publishers are not permitted to have any financial relationship with companies mentioned on the site. Mr. Boxer may recommend trades of stocks mentioned in the Diary as a consultant to hedge funds, but has agreed not to make such recommendations until after the stock has been posted on The Technical Trader Web site. Mr. Boxer's commentaries, trading ideas and model trades represent his own opinions and should not be relied upon for purposes of effecting securities transactions or other investing strategies, nor should they be construed as an offer or solicitation of an offer to sell or buy any security. You should not interpret Mr. Boxer's opinions as constituting investment advice. Neither we nor Mr. Boxer claim to have any non-public information regarding the companies mentioned in this site. The trade prices that appear on this Web site are based on the average of the real-time bid and real-time ask prices provided by Money.net, except when entered manually by Mr. Boxer should Money.net's feed be temporarily down. There may be a delay between the price as it appears in the diary and the current price that you see from your terminal due to delays in Internet connectivity, quote delays, refresh intervals in the case of the Web-based diary page, data entry errors, and market conditions, and also due to times when Mr. Boxer is not available to make the trade at the moment a previously stated target has been met. Entries may at times be in error due to system or data-entry errors. Hypothetical performance results do not include trading commissions and other execution costs that would be incurred if the trades referenced in the diary or elsewhere on the site were actual trades. Past performance is no guarantee of future results.
Recommended Content
Editors’ Picks
EUR/USD fluctuates in daily range above 1.0600
EUR/USD struggles to gather directional momentum and continues to fluctuate above 1.0600 on Tuesday. The modest improvement seen in risk mood limits the US Dollar's gains as investors await Fed Chairman Jerome Powell's speech.
GBP/USD stabilizes near 1.2450 ahead of Powell speech
GBP/USD holds steady at around 1.2450 after recovering from the multi-month low it touched near 1.2400 in the European morning. The USD struggles to gather strength after disappointing housing data. Market focus shifts to Fed Chairman Powell's appearance.
Gold aiming to re-conquer the $2,400 level
Gold stages a correction on Tuesday and fluctuates in negative territory near $2,370 following Monday's upsurge. The benchmark 10-year US Treasury bond yield continues to push higher above 4.6% and makes it difficult for XAU/USD to gain traction.
XRP struggles below $0.50 resistance as SEC vs. Ripple lawsuit likely to enter final pretrial conference
XRP is struggling with resistance at $0.50 as Ripple and the US Securities and Exchange Commission (SEC) are gearing up for the final pretrial conference on Tuesday at a New York court.
US outperformance continues
The economic divergence between the US and the rest of the world has become increasingly pronounced. The latest US inflation prints highlight that underlying inflation pressures seemingly remain stickier than in most other parts of the world.